Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

NCT: NCT06059638 · RECRUITING

NCT IDNCT06059638
StatusRECRUITING
Start Date2023-12-27
SponsorOrchestra BioMed, Inc (INDUSTRY)
First posted
Last updated

Brief Summary

A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑